Covid-19 vaccine launched in UK

Covid-19 vaccine launched in UK
Colin Kerr
Colin Kerr
Published: Tuesday, December 8, 2020
A 90-year-old woman has become the first person in the world to be given the Pfizer/BioNTech Covid-19 vaccine as part of the mass vaccination programme which started in the UK on Tuesday 8 December, 2021. The woman was named as Margaret Keenan, 90, originally from Enniskillen, Tyrone, Northern Ireland, and now resident in Coventry, England. Mrs Keenan received the first of 800,000 doses of the vaccine that will be given in the coming weeks. Her vaccine was administered at the University Hospital, Coventry, UK. The UK is the first country in the world to start using the Pfizer/BioNTech vaccine after regulators approved its use last week. The vaccine been given approval for use following a thorough review carried out by the Medicines and Healthcare products Regulatory Agency (MHRA) . The decision by the UK regulatory authority was made with advice from the Commission on Human Medicines (CHM), the government’s independent expert scientific advisory body. A dedicated team of MHRA scientists and clinicians carried out a rigorous, scientific and detailed review of all the available data, starting in October 2020. This was done using a regulatory process known as a ‘rolling review’. A ‘rolling review’ can be used to complete the assessment of a promising medicine or vaccine during a public health emergency in the shortest time possible. This is done as the packages of data become available from ongoing studies on a staggered basis. The MHRA expert scientists and clinicians reviewed data from the laboratory pre-clinical studies, clinical trials, manufacturing and quality controls, product sampling and testing of the final vaccine and also considered the conditions for its safe supply and distribution. https://www.gov.uk/government/news/uk-medicines-regulator-gives-approval-for-first-uk-covid-19-vaccine
Tags: covid 19 vaccine pfizer
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...